Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth
Rintaro Hashizume(Children's of Alabama), C. David James(Mayo Clinic in Arizona)
Cited by 123
Related Papers
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
|Neuro-Oncology|2008|387
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
|Molecular Cancer Therapeutics|2007|203
Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
|International Journal of Radiation Oncology*Biology*Physics|2010|186
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
|Journal of Neuro-Oncology|2008|97
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
|Molecular Cancer Therapeutics|2022|26